Jesús Cuervo holds a degree in Psychology, MSc in Clinical Psychology, in Pharmacoeconomics and Patient Reported Outcomes, and PhD in Health Sciences (Cum Laude).

He is the former Scientific Director of Patient Centred Outcomes at Analytica LASER in Spain and has over 15 years’ experience in Health Outcomes Research for Market Access and P&R (at both International and National levels).
Trained in the design of clinical research, psychometrics (qualitative and quantitative methods) and in advance statistical models, Dr. Cuervo is proficient in developing outcomes research, RWE and value assessments to robustly support MA centred strategies. During his career he has built a strong MA network in key EU markets. Considering his experience and background, he has proven leadership in patient engagement and in leveraging HTA and MA action plans by establishing trusted collaborations with multiple stakeholders.

As a PRO expert, he has completed the full development and transcultural adaptation of multiple questionnaires to assess patients’ Health-Related Quality of Life (HRQoL) and other endpoints in a wide range of pathologies: neurological, oncological, psychiatric, dermatological, pulmonary, cardiovascular, urological and rare diseases. In addition, as an international consultant, he is involved in the design and implementation of Multi-Criteria Decision Analysis (MCDA) for preference elicitation and the facilitation of informed and shared decision-making.

Finally, Dr. Cuervo has worked on the development and adaptation into Spain of multiple pharmacoeconomic models for renal, oncological, infectious, cardiovascular, rare diseases and medical devices, and is the author of multiple manuscripts in peer-review journals.

Carlos Crespo Palomo holds a PhD in statistics from the University of Barcelona and is a health economics expert. He graduated with a master’s degree in Advanced Studies in Statistics from the University of Barcelona, a Master in Business Administration by ESADE Business School (5th best European Business School and 1st Spanish by Financial Times) as well as a Master in Health Economics and Health Management from Pompeu Fabra University. Carlos completed a degree in research and market techniques from the University of Barcelona and a Bachelor of Science in Statistics from the Polytechnic University of Catalonia, a specialist in the field of healthcare.

He has held different management responsibilities, both in the field of health consulting and in market research companies, and in the global/national pharmaceutical industry. Carlos has also developed projects for various health corporations, coordinated projects of strategy, efficiency improvement, scorecards, market access, etc. in the field of health, pharmaceutical and public administration.

He is the founder & CEO of Axentiva Solutions and is also an adjunct professor at the University of Barcelona, and maintains his academic relationship with the Center for Research in Economics and Health (CRES) at Pompeu Fabra University and he collaborates with Center for Research in Healthcare Innovation Management (CHRIM) at IESE. Additionally, he is a reference speaker and author of scientific articles published in international journals.

Jesús Cuervo holds a degree in Psychology, MSc in Clinical Psychology, in Pharmacoeconomics and Patient Reported Outcomes, and PhD in Health Sciences (Cum Laude).

He is the former Scientific Director of Patient Centred Outcomes at Analytica LASER in Spain and has over 15 years’ experience in Health Outcomes Research for Market Access and P&R (at both International and National levels).
Trained in the design of clinical research, psychometrics (qualitative and quantitative methods) and in advance statistical models, Dr. Cuervo is proficient in developing outcomes research, RWE and value assessments to robustly support MA centred strategies. During his career he has built a strong MA network in key EU markets. Considering his experience and background, he has proven leadership in patient engagement and in leveraging HTA and MA action plans by establishing trusted collaborations with multiple stakeholders.

As a PRO expert, he has completed the full development and transcultural adaptation of multiple questionnaires to assess patients’ Health-Related Quality of Life (HRQoL) and other endpoints in a wide range of pathologies: neurological, oncological, psychiatric, dermatological, pulmonary, cardiovascular, urological and rare diseases. In addition, as an international consultant, he is involved in the design and implementation of Multi-Criteria Decision Analysis (MCDA) for preference elicitation and the facilitation of informed and shared decision-making.

Finally, Dr. Cuervo has worked on the development and adaptation into Spain of multiple pharmacoeconomic models for renal, oncological, infectious, cardiovascular, rare diseases and medical devices, and is the author of multiple manuscripts in peer-review journals.

Carlos Crespo Palomo holds a PhD in statistics from the University of Barcelona and is a health economics expert. He graduated with a master’s degree in Advanced Studies in Statistics from the University of Barcelona, a Master in Business Administration by ESADE Business School (5th best European Business School and 1st Spanish by Financial Times) as well as a Master in Health Economics and Health Management from Pompeu Fabra University. Carlos completed a degree in research and market techniques from the University of Barcelona and a Bachelor of Science in Statistics from the Polytechnic University of Catalonia, a specialist in the field of healthcare.

He has held different management responsibilities, both in the field of health consulting and in market research companies, and in the global/national pharmaceutical industry. Carlos has also developed projects for various health corporations, coordinated projects of strategy, efficiency improvement, scorecards, market access, etc. in the field of health, pharmaceutical and public administration.

He is the founder & CEO of Axentiva Solutions and is also an adjunct professor at the University of Barcelona, and maintains his academic relationship with the Center for Research in Economics and Health (CRES) at Pompeu Fabra University and he collaborates with Center for Research in Healthcare Innovation Management (CHRIM) at IESE. Additionally, he is a reference speaker and author of scientific articles published in international journals.

Jesús Cuervo holds a degree in Psychology, MSc in Clinical Psychology, in Pharmacoeconomics and Patient Reported Outcomes, and PhD in Health Sciences (Cum Laude).

He is the former Scientific Director of Patient Centred Outcomes at Analytica LASER in Spain and has over 15 years’ experience in Health Outcomes Research for Market Access and P&R (at both International and National levels).
Trained in the design of clinical research, psychometrics (qualitative and quantitative methods) and in advance statistical models, Dr. Cuervo is proficient in developing outcomes research, RWE and value assessments to robustly support MA centred strategies. During his career he has built a strong MA network in key EU markets. Considering his experience and background, he has proven leadership in patient engagement and in leveraging HTA and MA action plans by establishing trusted collaborations with multiple stakeholders.

As a PRO expert, he has completed the full development and transcultural adaptation of multiple questionnaires to assess patients’ Health-Related Quality of Life (HRQoL) and other endpoints in a wide range of pathologies: neurological, oncological, psychiatric, dermatological, pulmonary, cardiovascular, urological and rare diseases. In addition, as an international consultant, he is involved in the design and implementation of Multi-Criteria Decision Analysis (MCDA) for preference elicitation and the facilitation of informed and shared decision-making.

Finally, Dr. Cuervo has worked on the development and adaptation into Spain of multiple pharmacoeconomic models for renal, oncological, infectious, cardiovascular, rare diseases and medical devices, and is the author of multiple manuscripts in peer-review journals.